Annual EBIT:
-$338.85M-$116.25M(-52.22%)Summary
- As of today, CRNX annual earnings before interest & taxes is -$338.85 million, with the most recent change of -$116.25 million (-52.22%) on December 31, 2024.
- During the last 3 years, CRNX annual EBIT has fallen by -$231.15 million (-214.62%).
- CRNX annual EBIT is now -5540.05% below its all-time high of -$6.01 million, reached on December 31, 2016.
Performance
CRNX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$142.59M-$13.47M(-10.44%)Summary
- As of today, CRNX quarterly earnings before interest & taxes is -$142.59 million, with the most recent change of -$13.47 million (-10.44%) on September 30, 2025.
- Over the past year, CRNX quarterly EBIT has dropped by -$54.79 million (-62.40%).
- CRNX quarterly EBIT is now -5272.49% below its all-time high of -$2.65 million, reached on March 31, 2017.
Performance
CRNX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$477.85M-$54.79M(-12.95%)Summary
- As of today, CRNX TTM earnings before interest & taxes is -$477.85 million, with the most recent change of -$54.79 million (-12.95%) on September 30, 2025.
- Over the past year, CRNX TTM EBIT has dropped by -$170.04 million (-55.24%).
- CRNX TTM EBIT is now -17904.82% below its all-time high of -$2.65 million, reached on March 31, 2017.
Performance
CRNX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CRNX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -52.2% | -62.4% | -55.2% |
| 3Y3 Years | -214.6% | -224.7% | -207.8% |
| 5Y5 Years | -529.5% | -672.8% | -594.9% |
CRNX EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -214.6% | at low | -224.7% | at low | -207.8% | at low |
| 5Y | 5-Year | -529.5% | at low | -672.8% | at low | -594.9% | at low |
| All-Time | All-Time | -5540.1% | at low | -5272.5% | at low | >-9999.0% | at low |
CRNX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$142.59M(-10.4%) | -$477.85M(-13.0%) |
| Jun 2025 | - | -$129.11M(-15.9%) | -$423.06M(-12.2%) |
| Mar 2025 | - | -$111.41M(-17.6%) | -$377.13M(-11.0%) |
| Dec 2024 | -$338.85M(-52.2%) | -$94.75M(-7.9%) | -$339.89M(-10.4%) |
| Sep 2024 | - | -$87.80M(-5.5%) | -$307.81M(-10.2%) |
| Jun 2024 | - | -$83.18M(-12.2%) | -$279.33M(-11.7%) |
| Mar 2024 | - | -$74.17M(-18.4%) | -$250.13M(-10.4%) |
| Dec 2023 | -$222.61M(-32.6%) | -$62.66M(-5.6%) | -$226.62M(-7.1%) |
| Sep 2023 | - | -$59.32M(-9.9%) | -$211.52M(-7.9%) |
| Jun 2023 | - | -$53.98M(-6.6%) | -$196.11M(-5.7%) |
| Mar 2023 | - | -$50.66M(-6.5%) | -$185.61M(-8.0%) |
| Dec 2022 | -$167.88M(-55.9%) | -$47.56M(-8.3%) | -$171.91M(-10.7%) |
| Sep 2022 | - | -$43.91M(-1.0%) | -$155.24M(-11.6%) |
| Jun 2022 | - | -$43.48M(-17.7%) | -$139.14M(-14.3%) |
| Mar 2022 | - | -$36.96M(-19.7%) | -$121.74M(-13.0%) |
| Dec 2021 | -$107.70M | -$30.89M(-11.1%) | -$107.70M(-9.2%) |
| Sep 2021 | - | -$27.81M(-6.6%) | -$98.61M(-10.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$26.09M(-13.8%) | -$89.25M(-11.4%) |
| Mar 2021 | - | -$22.92M(-5.2%) | -$80.09M(-6.8%) |
| Dec 2020 | -$74.95M(-39.2%) | -$21.79M(-18.1%) | -$75.02M(-9.1%) |
| Sep 2020 | - | -$18.45M(-9.0%) | -$68.77M(-4.1%) |
| Jun 2020 | - | -$16.93M(+5.2%) | -$66.05M(-5.7%) |
| Mar 2020 | - | -$17.85M(-14.9%) | -$62.47M(-13.5%) |
| Dec 2019 | -$53.83M(-87.5%) | -$15.54M(+1.3%) | -$55.02M(-10.7%) |
| Sep 2019 | - | -$15.73M(-17.9%) | -$49.70M(-16.7%) |
| Jun 2019 | - | -$13.35M(-28.2%) | -$42.59M(-19.7%) |
| Mar 2019 | - | -$10.41M(-1.9%) | -$35.58M(-14.3%) |
| Dec 2018 | -$28.71M(-214.6%) | -$10.21M(-18.5%) | -$31.14M(-48.8%) |
| Sep 2018 | - | -$8.62M(-35.9%) | -$20.93M(-36.6%) |
| Jun 2018 | - | -$6.34M(-6.2%) | -$15.32M(-70.6%) |
| Mar 2018 | - | -$5.97M(-98.0%) | -$8.98M(-58.5%) |
| Dec 2017 | -$9.13M(-51.9%) | - | - |
| Sep 2017 | - | -$3.01M(-13.6%) | -$5.67M(-113.6%) |
| Mar 2017 | - | -$2.65M | -$2.65M |
| Dec 2016 | -$6.01M | - | - |
FAQ
- What is Crinetics Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Crinetics Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of CRNX is -$338.85M
What is the all-time high annual EBIT for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is -$6.01M
What is Crinetics Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, CRNX annual earnings before interest & taxes has changed by -$116.25M (-52.22%)
What is Crinetics Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of CRNX is -$142.59M
What is the all-time high quarterly EBIT for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is -$2.65M
What is Crinetics Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, CRNX quarterly earnings before interest & taxes has changed by -$54.79M (-62.40%)
What is Crinetics Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of CRNX is -$477.85M
What is the all-time high TTM EBIT for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is -$2.65M
What is Crinetics Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, CRNX TTM earnings before interest & taxes has changed by -$170.04M (-55.24%)